Outlets Highlight New NIH Grant to Study Biological Mechanisms of Alzheimer’s Received by Dr. John Elrod and Lewis Katz School of Medicine Colleagues

Thanks to a new three-year, $2.27 million grant from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, John W. Elrod, PhD, Associate Professor in the Center for Translational Medicine at the Lewis Katz School of Medicine at Temple University, and colleagues are poised to gain novel insight into biological mechanisms that may be driving or worsening neurodegeneration. The researchers will investigate potential mechanisms using mouse models of Alzheimer’s disease and a systems biology approach. The work could help identify new drug targets and therapeutic opportunities for Alzheimer’s disease. Outlets including Scienmag and Bioengineer.org highlighted the news.